PSMB8 and experimental autoimmune encephalomyelitis: In a previous study, we found that both targeting β5c in LMP7−/− mice or LMP7 in WT mice can ameliorate symptoms in experimental autoimmune encephalomyelitis in a bone-marrow-cell-dependent manner, rendering reduced proteasome activity rather than a strictly LMP7-dependent factor as the likely underlying mechanism (20).